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Abstract
We previously reported that in an orthotopic nude mouse model of human colon cancer, bone marrow–derived
mesenchymal stem cells (MSCs) migrated to the tumor stroma and promoted tumor growth and metastasis. Here,
we evaluated the proliferation and migration ability of cancer cells cocultured with MSCs to elucidate the
mechanism of interaction between cancer cells and MSCs. Proliferation and migration of cancer cells increased
following direct coculture with MSCs but not following indirect coculture. Thus, we hypothesized that direct
contact between cancer cells and MSCs was important. We performed a microarray analysis of gene expression in
KM12SM colon cancer cells directly cocultured with MSCs. Expression of epithelial-mesenchymal transition
(EMT)–related genes such as fibronectin (FN), SPARC, and galectin 1 was increased by direct coculture with
MSCs. We also confirmed the upregulation of these geneswith real-time polymerase chain reaction. Gene expression
was not elevated in cancer cells indirectly coculturedwithMSCs. Among the EMT-related genes upregulated by direct
coculture with MSCs, we examined the immune localization of FN, a well-known EMT marker. In coculture assay in
chamber slides, expression of FNwas seen only at the edges of cancer clusters where cancer cells directly contacted
MSCs. FN expression in cancer cells increased at the tumor periphery and invasive edge in orthotopic nude mouse
tumors and human colon cancer tissues. These results suggest thatMSCs induce EMT in colon cancer cells via direct
cell-to-cell contact and may play an important role in colon cancer metastasis.
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Introduction
Colorectal cancer (CRC) is the third most common cancer and a
major cause of mortality worldwide [1]. Many studies have indicated
that tumor growth and metastasis are determined by both tumor cells
and stromal cells. The stroma constitutes a large percentage of most
solid tumors, and tumor-stromal cell interactions contribute to
tumor growth and metastasis [2,3]. Of the constituents of the tumor
stroma, it has become clear that activated fibroblasts, known as
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carcinoma-associated fibroblasts (CAFs), promote tumor growth
and metastasis [4–6].
We previously reported that mesenchymal stem cells (MSCs)
incorporated into the stroma of primary and metastatic tumors
expressed α-smooth muscle actin and platelet-derived growth factor
receptor-β as CAF markers. KM12SM cells recruited MSCs, and
MSCs stimulated migration and invasion of tumor cells. MSCs
migrate and differentiate into CAFs in the tumor stroma [7].
Coimplantation of KM12SM cells with MSCs into the cecal walls of
nude mice produced tumors with abundant stromal components and
promoted tumor growth and lymph node metastasis by enhancing
angiogenesis, migration, and invasion and by inhibiting apoptosis of
tumor cells [8].
MSCs may provide delivery vehicles for antitumor biological
agents because of their ability to migrate to tumors [9]. A number of
antitumor genes have been engineered into MSCs and have
demonstrated antitumor effects on various cancer models [10–18].
However, there are potential concerns in using MSCs as delivery
vehicles; we understand little about the fate of this cell population in
vivo [19,20], and there is a possibility that MSCs themselves might
enhance or initiate tumor growth [21–23].
It has been shown that MSCs can promote tumor proliferation and
expression of an epithelial-mesenchymal transition (EMT) phenotype
in several cancer cells via expression of proteins including TWIST,
MMP, WNT5A, and TGF-β type I receptor [24–26], many of which
act in a paracrine manner. Previous reports have suggested that
paracrine factors expressed by MSCs affect cancer cells. However, this
does not necessarily mean that the interaction between cancer cells
and MSCs is paracrine in nature. Whereas some reports have
indicated that the interaction between cancer cells and MSCs is
regulated via paracrine signaling [27], other reports have indicated
that the interaction may be regulated via juxtacrine signaling [28].
The mechanism of secretion and interaction between cancer cells and
MSCs therefore remains to be elucidated.
Thus, in this study, we examined tumor-MSC interactions via
direct and indirect coculture of KM12SM colon cancer cells and bone
marrow–derived MSCs using cDNA microarray analysis. Direct
coculture of MSCs increased proliferation and migration of cancer
cells and expression of EMT-related genes such as fibronectin (FN).
In addition, coimplantation of MSCs with cancer cells increased the
expression of FN at the edges of orthotopic colon cancer tumors,
where the tumor stroma directly contacted cancer cells. Expression of
FN was correlated with invasion depth of human colorectal
carcinoma based on analysis of surgical specimens. Taken together,
we found that MSCs promote the progression of colon tumors by
inducing EMT through direct cell-to-cell contact.
Material and Methods
Human Colon Carcinoma Cell Line and Culture Conditions
The human colon cancer cell line KM12SM [29] was kindly
donated by Dr. Isaiah J. Fidler (University of Texas, Houston, TX).
The KM12SM cell line is a highly metastatic clonal cell line selected
from the parental KM12C cell line. Cells were maintained in
Dulbecco's modified Eagle's medium (DMEM) with 10% fetal
bovine serum (FBS; Sigma-Aldrich, St. Louis, MO) and a
penicillin-streptomycin mixture. Cultures were maintained for no
longer than 12 weeks after recovery of cells from frozen stock.
Transfection and Selection of Stable KM12SM Cells Expressing
Green Fluorescent Protein
Green fluorescent protein (GFP) and puromycin resistance genes
were transfected into KM12SM colon cancer cells using copGFP
Control Lentiviral Particles (sc-108,084; Santa Cruz Biotechnology)
according to the manufacturer's protocol. Cells were maintained in
complete medium containing puromycin.
Isolation and Culture of Human MSCs
HumanMSCs were obtained from the iliac crest and plated in a dish
with DMEM supplemented with 10% FBS, L-glutamine, and a
penicillin-streptomycin mixture according to a protocol approved by
the Ethics Committee of Hiroshima University Graduate School of
Medicine, as described previously [30]. Nonadherent cells were
removed after 72 hours, and adherent cells were detached from the
plates and subcultured every 4 to 5 days in freshmedium supplemented
with 1 ng/ml of fibroblast growth factor-2 [31]. Aliquots from passages
3 to 5 were frozen in liquid nitrogen for future use.
Characterization of Human MSCs In Vitro
In culture medium, MSCs formed a monolayer of adherent cells
and appeared as long, spindle-shaped fibroblastic cells. Capacity for
chondrogenic, adipogenic, and osteogenic differentiation was con-
firmed with the use of a Human Mesenchymal Stem Cell Functional
Identification Kit (R&D Systems, Minneapolis, MN). Cell surface
antigens on the cells were analyzed by fluorescence-activated cell
sorting (FACS), and we confirmed that the cells were positive for
CD29, CD44, CD73, CD90, CD105, CD166, and MHC-DR but
negative for CD14, CD34, and Flk-1, as described previously [30].
Preparation of Conditioned Medium
For preparation of conditioned medium from MSCs, cells were
seeded on 100-mm cell culture dishes and cultured in fresh medium
supplemented with 10% FBS, L-glutamine, a penicillin-streptomycin
mixture, and 1 ng/ml of fibroblast growth factor-2 until reaching
confluence. Cells were briefly rinsed twice with phosphate-buffered
saline (PBS), followed by incubation with 10 ml of medium
supplemented with 0.5% FBS for 48 hours prior to collection of
culture medium. Culture supernatants were centrifuged at 700×g for
10 minutes for removal of cell debris.
Evaluation of Cell Proliferation and Motility In Vitro
KM12SM colon cancer cell lines (6 × 104 cells per well) were
seeded into 24-well plates (Essen ImageLock; Essen Bioscience, Ann
Arbor, MI) containing DMEM supplemented with 0.5% FBS.
KM12SM cells were cultured alone, with MSCs (6 × 104 cells per
well), or with MSC-conditioned medium (MSC-CM). Growth
curves were generated from a bright-field image obtained using a
label-free, high-content time-lapse assay system (IncuCyte Zoom;
Essen Bioscience) that automatically expresses cell confluence as a
percentage over a 4-day period. All experiments were performed in
triplicate.
Cell migration was assessed by performing a scratch wound assay.
KM12SM colon cancer cells (1 × 105 cells per well) were seeded in
100 μg/l Matrigel-coated (BD Biosciences, Bedford, MA) 96-well
plates (Essen ImageLock) containing DMEM supplemented with
0.5% FBS. Cancer cells were cultured alone, with MSCs (1 × 105
cells per well), or with MSC-CM. Use of ImageLock 96-well plates
allows wound images to be taken automatically at exact locations
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using IncuCyte software. Confluent cell layers were scratched using a
96-pin wound maker provided by IncuCyte [32]. After inducing
wounds, cells were washed twice with PBS to remove detached cells,
and wound images were acquired automatically every 3 hours over a
2-day period. Relative wound density was analyzed automatically by
IncuCyte software. All experiments were performed in triplicate.
FACS-Based Isolation of KM12SM Cells from Direct
MSC Coculture
KM12SM cells were red-labeled with PKH26-GL (Sigma-Aldrich)
according to the manufacturer's protocol. PKH26-GL–labeled
KM12SM cells were seeded onto 100-mm dishes at a density of
1 × 104 per well in DMEM supplemented with 0.5% FBS with and
without 8 × 105 MSCs. After 24 hours of incubation, cells were
subjected to FACS analysis to yield PKH26-GL–positive KM12SM
cells according to a standard protocol. RNA samples for microarray
analysis were extracted from KM12SM cell culture with an RNeasy
Kit (Qiagen, Valencia, CA) according to the manufacturer's
instructions.
Isolation of KM12SM Cells from Indirect Coculture
KM12SM cells were seeded onto 100-mm dishes at a density of
1 × 104 per well in DMEM supplemented with 0.5% FBS with and
without MSC-CM. After 24 hours of incubation, RNA samples for
microarray analysis were extracted from KM12SM cell culture with
an RNeasy Kit (Qiagen) according to the manufacturer's instructions.
Microarray Analysis
For oligo DNA microarray analysis, RNA samples were extracted
from KM12SM cells cultured alone and KM12SM cells directly
cocultured with MSCs. Isolation of KM12SM cells was performed as
described above. RNA samples from KM12SM cells in monolayer
culture without MSCs represented the control condition. For
microarray analysis, a 3D-Gene Human Oligo Chip 25k (Toray
Industries Inc., Tokyo, Japan) was used. For efficient hybridization,
this microarray is constructed in three dimensions, with a well as the
space between the probes and cylinder stems and with 70-mer
oligonucleotide probes on the top. Total RNA was labeled with Cy3
(KM12SM cells cultured alone) or Cy5 (KM12SM cells with MSCs)
using the Amino Allyl MessageAMP II aRNA Amplification Kit
(Applied Biosystems, Carlsbad, CA). Cy3- or Cy5-labeled aRNA
pools were mixed with hybridization buffer and hybridized for 16
hours. Hybridization was performed using the supplier's protocols
(www.3d-gene.com). Hybridization signals were obtained using
3D-Gene Scanner (Toray Industries Inc.) and processed by
3D-Gene Extraction (Toray Industries Inc.). Detected signals for
each gene were normalized using a global normalization method
(Cy5/Cy3 ratio median = 1). Genes with Cy5/Cy3 normalized ratios
greater than 2.0 or less than 0.5 were defined as up- or downregulated
genes, respectively.
Quantitative Reverse Transcription Polymerase Chain
Reaction
Total RNA was extracted from gastric cancer cell lines and biopsy
specimens with an RNeasy Kit (Qiagen) according to the manufac-
turer's instructions. cDNA was synthesized from 1 μg total RNA with
a first-strand cDNA synthesis kit (Amersham Biosciences, Piscataway,
NJ). After reverse transcription of RNA into cDNA, quantitative
reverse transcription polymerase chain reaction (qRT-PCR) was
performed with a LightCycler FastStart DNA Master SYBR Green I
Kit (Roche Diagnostics, Basel, Switzerland) according to the
manufacturer's recommended protocol. Reactions were carried out
in triplicate. To correct for differences in both RNA quality and
quantity between samples, expression values were reported as log 2
ratios, normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and mean-centered. Primers for PCR were designed
with specific primer analysis software (Primer Designer; Scientific and
Educational Software, Cary, NC), and sequence specificity was
confirmed by FASTA (European Molecular Biology Laboratory
Database, Heidelberg, Germany). Primer sequences are provided in
Table 1.
Animals and Transplantation of Tumor Cells
Animal experiments were performed previously [33]. Briefly,
female athymic BALB/c nude mice were obtained from Charles River
Japan (Tokyo, Japan). The mice were maintained under specific
pathogen-free conditions and used at 8 weeks old. Study was carried
out after permission was granted by the Committee on Animal
Experimentation of Hiroshima University. To produce cecal tumors,
KM12SM cells alone (0.5 × 106) or KM12SM cells mixed with
MSCs in a ratio of 1:2 (0.5 × 106:1.0 × 106 KM12SM:MSCs) in
50 μl of Hanks' balanced salt solution were injected into the cecal
walls of nude mice under a dissecting microscope as described
previously [4]. Six weeks after intracecal transplantation of these cells,
surviving mice were sacrificed. To evaluate the migration and
colocalization of MSCs in orthotopic tumors, 1.0 × 106 KM12SM
cells were transplanted into the cecal walls of three mice on day 0.
Three weeks after tumor cell transplantation (on day 21), each mouse
underwent injection of 1.0 × 106 PKH26-GL–labeled MSCs in
200 μl of Hanks' balanced salt solution into the tail vein. One week
after this injection (on day 28), the mice were killed and necropsied.
Tumor tissue was embedded in OCT Compound, rapidly frozen in
liquid nitrogen, and stored at −80°C. For this study, we performed
only additional analyses using the frozen sections obtained in the
previous study [33].
Immunohistochemical Staining of Formalin-Fixed Sections
Formalin-fixed, paraffin-embedded tissues cut into serial 4-mm
sections were used for immunohistochemistry. The procedures for
immunohistochemical detection of FN have been described
previously [34].
Table 1. Primers Used in This Study for Quantitative Real-Time PCR
Gene Symbol Direction Sequence (5′-3′) Product Size (bp)
MT1E Forward tcctgcaagtgcaaagagtg 222
Reverse cagcaaatggctcagtgttg
MT2A Forward gcaaatgcaaagagtgcaaa 222
Reverse atagcaaacggtcacggtca
SPARC Forward atgagggcctggatcttctt 192
Reverse ctcttcggtttcctctgcac
FSTL1 Forward gcacaggcaactgtgagaaa 242
Reverse catagtgtccaagggctggt
FN1 Forward accaacctacggatgactcg 230
Reverse gctcatcatctggccatttt
PTX3 Forward gtgggtggagaggagaacaa 175
Reverse ttcctccctcaggaacaatg
LGALS1 Forward ctctcgggtggagtcttctg 158
Reverse acgaagctcttagcgtcagg
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Immunofluorescence Staining of Frozen Sections and
Formalin-Fixed Sections
Transplanted tumor tissues were prepared into 10-mm frozen
sections and were then subjected to immunofluorescence analyses.
The procedures for immunofluorescent staining of frozen sections
were described previously [7]. For immunofluorescent staining of
surgical specimens, formalin-fixed, paraffin-embedded tissues cut into
serial 4-mm sections were treated with an Opal Fluorescent IHC Kit
(Perkin Elmer, Norwalk, CT) according to the manufacturer's
instructions. Primary antibodies used included goat polyclonal
anti-fibronectin antibody and rabbit polyclonal anti-E-cadherin
(Santa Cruz Biotechnology, Santa Cruz, CA). The fluorescent signal
of secondary antibody was captured by confocal laser-scanning
microscopy (Carl Zeiss Microscopy, Thornwood, NY).
Chamber Slides System
To evaluate the localization of FN expression in KM12SM cells
cultured alone, KM12SM cells were seeded into a chamber slide
system with DMEM supplemented with 0.5% FBS. After 48 hours of
incubation, cells were rinsed with PBS and fixed with 4%
paraformaldehyde for immunofluorescence staining.
To evaluate the localization of FN expression in KM12SM cells
cocultured with MSCs-CM, KM12SM cells were seeded into a
chamber slide system with DMEM supplemented with 0.5% FBS
with MSC-CM. After 48 hours of incubation, cells were rinsed with
PBS and fixed with 4% paraformaldehyde for immunofluorescence
staining.
To evaluate the localization of FN expression in KM12SM cells
directly cocultured with MSCs, KM12SM cells and MSCs were
seeded into a chamber slide system separately by cloning ring, and
DMEM supplemented with 0.5% FBS was added. KM12SM cells
were cultured inside the cloning ring, and MSCs were cultured
outside the cloning ring. After 24 hours of incubation, the cloning
ring was removed. After another 24 hours of incubation, cells were
rinsed with PBS and fixed with 4% paraformaldehyde for
immunofluorescence staining.
Immunofluorescence staining was performed using the Opal
Fluorescent IHC Kit according to the manufacturer's protocol. Goat
polyclonal anti-fibronectin antibody (Santa Cruz Biotechnology) was
used as a primary antibody. The fluorescent signal of secondary
antibody was captured by confocal laser-scanning microscopy (Carl
Zeiss Microscopy).
Patients and Surgical Specimens
Archival formalin-fixed, paraffin-embedded tumor tissues were
obtained from Hiroshima University Hospital. Specimens from 89
patients who underwent surgical resection for colon dysplasia and cancer
were examined by immunohistochemistry. Patient privacy was protected
in accordance with the Ethical Guidelines for Human Genome/Gene
Research of the Japanese Government. All personally identifiable
information was removed before analysis of the tissue samples.
Results
Direct Contact with MSCs Enhanced Proliferation and
Migration of KM12SM Cells
We first examined the effect of MSCs on the proliferation and
migration of KM12SM cells. KM12SM-GFP cells were cultured
alone with fresh medium (control), with MSC-CM (indirect
Table 2. Genes with Upregulated mRNA Expression in KM12SM Cells Directly Cocultured with
MSCs
Gene
Name
KM12SM Alone
(Normalized Cy5 Intensity)
KM12SM + MSCs Direct Coculture
(Normalized Cy3 Intensity)
SPARC 6 636
PTX3 6 140
FN1 17 371
FSTL1 16 146
LGALS1 31 270
Table 3. Comparison between Fibronectin-Positive and Fibronectin-Negative Cases of Dysplasia and Colorectal Carcinoma among Surgical Specimens
FN Expression P
Positive Negative
Number of patients 51 38
Age (years old) 66.0 ± 11.7 68.2 ± 9.0 .25
Median of observation period (year) 5 4.8 .41
Location Right side colon 15 (56%) 12 .98
Left side colon 36 (58%) 26
Morphological type Depressed type 10 (56%) 8 .92
Elevated type 41 (58%) 30
Histological type (excluding unknown cases) tub1 40 (54%) 34 .95
tub2 4 (50%) 4
Degree of progression (dysplasia vs SM or Adv Ca) Dysplasia 10 (26%) 29 .0027*
SM or Adv Ca 40 (82%) 9
INF (excluding unknown cases) a 4 (36%) 7 .48
b or c 18 (55%) 15
Quantity of stroma (excluding unknown cases) Med 4 (57%) 3 .66
Int or Sci 18 (69%) 8
Lymphatic and/or blood vessel invasion Yes 16 (80%) 4 .022*
No 35 (51%) 33
Lymph node metastasis Yes 11 (92%) 1 .011*
No 40 (52%) 37
Other organ metastasis Yes 4 (100%) 0 .13
No 47 (55%) 38
SM, submucosal invasive carcinoma; Adv Ca, advanced carcinoma;
Med, medullary; Int, intermediate; Sci, scirrhous.
*P b .05.
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coculture group), or with MSCs (direct coculture group). The
proliferation and migration abilities of KM12SM cells were highest in
the direct coculture group (Figure 1, A and B). The proliferation and
migration of KM12SM cells were not affected by coculture with
MSC-CM (Figure 1, C and D), suggesting that direct cell-cell contact
is necessary for enhancement of proliferation and migration.
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Figure 1. In vitro cell proliferation and migration of KM12SM cells. (A) Proliferation and (B) migration abilities of KM12SM cells cocultured
with MSCs compared with those of KM12SM cells cultured alone. (C) Proliferation and (D) migration abilities of KM12SM cells cocultured
with MSC-CM (indirect coculture) compared with those of KM12SM cells cultured alone.Time-lapse imaging (obtained with IncuCyte
Zoom) of morphology of KM12SM cells cultured (E) alone, (F) with MSCs, or (G) with MSC-CM for 48 hours. Scale bar =100 μm.
Table 4. Comparison between Fibronectin-Positive and Fibronectin-Negative Cases of Submucosal Invasive Colorectal Carcinoma among Surgical Specimens
FN expression P
Positive Negative
Number of patients 28 16
Age (years old) 68.0 ± 11.7 70.9 ± 12.5 .24
Median of observation period (year) 5.2 4.7 .80
Location Right side colon 8 (57%) 6 .78
Left side colon 20 (43%) 10
Morphological type Depressed type 6 (55%) 5 .71
Elevated type 22 (67%) 11
Histological type (excluding unknown cases) tub1 18 (64%) 10 .91
tub2 8 (57%) 6
Depth of SM invasion (μm) 2657 ± 1889 2365 ± 2028 0.39
INF (excluding unknown cases) a 2 (100%) 0 .60
b or c 9 (53%) 8
Quantity of stroma (excluding unknown cases) Med 2 (40%) 3 .71
Int or Sci 10 (63%) 6
Lymphatic and/or blood vessel invasion Yes 11 (78%) 3 .19
No 17 (57%) 13
Lymph node metastasis Yes 9 (100%) 0 .031*
No 19 (54%) 16
Other organ metastasis Yes 2 (100%) 0 .73
No 26 (62%) 16
Budding grade Low 18 (56%) 14 .030*
High 10 (83%) 2
*P b .05.
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Morphological Changes and Movement of KM12SM Cells in
Contact with MSCs
We next examined the effect of MSCs on the morphology of
KM12SM cells. Time-lapse imaging was used to observe the
morphology and movement of the cells. MSC-CM did not affect
the morphology of KM12SM-GFP cells (Figure 1F). KM12SM-GFP
cells directly attached to MSCs, however, exhibited a change in shape
from cobblestone-like to spindle-like. These spindle-like cells were
able to detach from tumor cell nests.
cDNA Microarray Analysis of KM12SM Colon Cancer Cells
Cocultured with MSCs
To determine the genes involved in these phenomena, cDNA
microarray analysis was performed using mRNAs extracted from each
experimental group of KM12SM cells. Expression levels of secreted
protein, acidic and rich in cysteine precursor (SPARC);
pentraxin-related protein PTX3 precursor (PTX3); fibronectin precur-
sor (FN1); follistatin-related protein 1 precursor (FSTL1); and
galectin-1 (LGALS1) were higher in KM12SM cells directly cocultured
with MSCs compared with levels in KM12SM cells cultured alone
(Table 2 and Figure 2A). Validation of gene expression was performed
by qRT-PCR (Figure 2B). Among these EMT-related genes, qRT-PCR
analysis revealed that the FN gene was particularly upregulated when
KM12SM cells were directly cocultured with MSCs. In contrast,
expression of the above EMT-related genes was not significantly altered
by indirect coculture with MSC-CM (Figure 2C).
FN Expression in KM12SM Cells Is Enhanced by Direct
Contact with MSCs
Expression of FN was examined by time-lapse immunofluores-
cence at the cell level. KM12SM cells and MSCs were separately
cultured using cloning rings. After removal of the separating ring,
cell-to-cell surface lesions between KM12SM cells and MSCs were
observed by confocal laser-scanning microscopy. Strong FN
expression was observed only in MSCs and at the edges of
KM12SM cell clusters where KM12SM cells were in direct contact
with MSCs (Figure 3A, lower panel). FN expression was not observed
in KM12SM cells cultured alone or KM12SM cells cocultured with
MSC-CM (Figure 3A, upper and middle panels).
Colocalization of FN Expression in Tumor-Bearing Mice after
Injection of PKH26-GL-Labeled MSCs
After injection of PKH26-GL–labeled MSCs into the tail veins of
KM12SM tumor-bearing mice, MSCs were detected selectively in the
tumor stroma. Expression of FN was seen in the tumor stroma and at
the edges of cancer nests where MSCs were in contact with cancer
cells (Figure 3B).
Effect of MSC Coimplantation in Orthotopic Nude Mouse
Model
In tumors generated by orthotopic implantation of KM12SM cells
alone, expression of FN at the edges of cancer nests was relatively low,
and E-cadherin expression in cancer nests was homogeneous. Marked
EMT was not observed (Figure 3C). In contrast, in tumors generated
by coimplantation of KM12SM cells and MSCs, expression of FN
was seen not only in the tumor stroma but also at the edges of cancer
nests in contact with the tumor stroma. Expression of E-cadherin was
elevated in the centers of tumor nests but lower at the edges of cancer
nests (Figure 3D). These results indicate that coimplantation of
MSCs promotes EMT in vivo via direct contact between MSCs and
cancer cells.
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FN Expression in Surgical Specimens
To examine EMT localization, we performed immunostaining for
FN in colorectal dysplasias and adenocarcinomas of surgical
specimens. Degree of progression, as well as rates of lymphatic and
vessel invasion and lymphatic metastasis, was higher in FN-positive
patients than in FN-negative patients (Table 3). Subsequently, to
evaluate the difference between FN-positive patients and FN-negative
patients with similar depths of invasion, we analyzed the submucosal
invasive adenocarcinomas and divided them into an FN-positive
group and an FN-negative group. The characteristics of both groups
are as shown in Table 4. There were no significant differences
between the groups in patient age, tumor location, histological type,
depth of submucosal invasion, infiltration (INF), quantity of stroma,
or other organ metastasis. However, lymphatic invasion, metastasis,
and budding grade were significantly higher in the FN-positive group
(Table 4).
High expression of FN was seen not only in the stromal area but
also at the invasive edges of cancer cells close to the stromal area
(Figure 4A). In addition, expression of FN was seen in budding cells
(Figure 4B). Furthermore, EMT was not observed in FN-negative or
low–budding grade patients, whereas EMT was active in FN-positive
and high–budding grade patients (Figure 4C). Kaplan-Meier survival
curves revealed that overall survival was significantly reduced in the
FN-positive group compared with that in the FN-negative group
(Figure 4D).
Discussion
EMT is a common process during wound healing and organ fibrosis
in which epithelial cells undergo morphological changes resulting in
increased cell plasticity and mobility as they transition into a
mesenchymal-like cell phenotype. EMT can be also observed in a
variety of cancer tissues. In human CRC, EMT is often detected at
invasive lesions and tumor peripheries at the interface between cancer
cells and host cells surrounded by extracellular matrix (ECM). EMT
enhances the motility and invasion of tumor cells and thereby may
result in metastasis.
In the present study, we demonstrated that direct contact between
cancer cells and MSCs plays an important role in the induction of
EMT in tumor cells. In culture, only tumor cells that are directly
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(A) In vitro expression of FN (red) in KM12SM-GFP colon cancer cells (green) cultured alone (upper panels), with MSC-CM (middle panels),
or with MSCs (lower panels). Merged images show regions of overlap. C, KM12SM cancer cells; M, MSCs. Scale bar =50 μm. (B)
Expression of FN (green) after injection of PKH26-GL–labeled MSCs (red) into the tail veins of KM12SM tumor-bearing mice. DAPI nuclear
staining is shown in blue. Merged image shown in the lower right. T, tumor; S, stroma. Scale bar =50 μm. (C) Expression of FN (green) and
E-cadherin (red) in tumors generated by implantation of KM12SM cells only. DAPI nuclear staining is shown in blue. Merged image shown
in the lower right. T, tumor; S, stroma. Scale bar =50 μm. (D) Expression of FN (green) and E-cadherin (red) in tumors generated by
coimplantation of KM12SM cells and MSCs. DAPI nuclear staining is shown in blue. Merged image shown in the lower right. T, tumor; S,
stroma. Scale bar =50 μm.
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attached to MSCs showed morphological changes to
mesenchymal-like cells. In contrast, no morphological changes were
observed following the treatment of cancer cells with MSC-CM.
Furthermore, microarray analysis showed that several genes involved
in EMT were upregulated in tumor cells following direct coculture
with MSCs. Pathway analysis also revealed enrichment for pathways
related to matrix metalloproteinases (data not shown), which are well
known EMT promoters [24]. Expression levels of FN, SPARC,
LGALS1, PTX3, and FSTL were markedly upregulated in our
microarray analysis. There are a few reports regarding the relationship
between EMT and PTX3/FSTL [35,36], but it has not yet been
elucidated how these affect EMT. SPARC is a matricellular protein
known to be a marker of poor prognosis in different cancer types; it is
involved in EMT, immune surveillance, and angiogenesis [37].
Furthermore, SPARC promotes migration activity in cancer cells [38]. It
has been reported that LGALS1 promotes EMT and that its expression
correlates with cancer growth, invasiveness, and metastasis [39]. Among
these upregulated genes, we focused on FN because it is a well-known
EMT marker and EMT-promoting factor [40]. Thus far, it has been
reported that cancer cells express soluble factors when interacting with
MSCs and that these soluble factors promote tumor progression in a
paracrine manner [41,42]. However, it has also been reported thatMSCs
affect cardiomyocytes via a juxtacrine signaling mechanism [43,44].
There have been a few reports that have revealed the importance of direct
cell-to-cell contact in the cross talk between cancer cells andMSCs. These
showed that MSCs interact with cancer cells by inducing cancer cells to
shed amphiregulin via juxtacrine signaling [28]. We found that FN
expression was induced only by direct contact with MSCs in vitro and
in vivo. We therefore present the novel findings that MSCs interact with
cancer cells by cell-to-cell contact and that the interaction is mediated by
EMT-related proteins such as FN. Other EMT-related genes that were
significantly upregulated in our study, such as SPARC and galectin, are
also of great interest.We speculate that these genes play a complementary
role, such as enhancement of FN expression by SPARC [38]. The
identification of genes with large effects as well as the mechanisms by
which these genes interact to promote cancer progression remains subjects
for future study.
The ECM is a key component of the cancer microenvironment and
cooperates with other extracellular molecules to relay external signals
into cells. FN is an ECM glycoprotein that plays roles in cell-substrate
interactions, including cell adhesion, and appears to be important for
differentiation and oncogenic transformation. Alteration of the ECM
composition in cancer may be responsible for the tissue remodeling
processes that are linked to cancer progression. Many reports have
shown that expression of FN is upregulated in several cancer tissues,
including colon cancer [45–48]. Furthermore, FN expression is
reported to be absent from normal connective tissues, whereas
increased FN expression levels have been detected in the tumor
stroma [46,48].
FN is a well-known mesenchymal marker, and thus EMT increases
FN expression. Park et al. reported that FN is not only an EMT
marker but also a promoter of EMT [40]. They demonstrated that
FN initiates EMT under serum-free conditions by enhancing the
effect of endogenous TGFβ. They proposed that increased FN levels
in breast cancer may be both a cause and an effect of tumor initiation
and/or progression.
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Figure 4. Expression of FN in surgical specimens of human colon tumors. (A) Expression of FN in the stromal area and at the invasive
edges of cancer cells close to the stromal area. (B) Expression of FN in budding cells. (C) Expression of FN (green) and E-cadherin (red) in
FN-negative/low–budding grade and FN-positive/high–budding grade patients. DAPI nuclear staining is shown in blue. Merged image
shown in lower right. (D) Kaplan-Meier survival curves showing overall survival in FN-positive and FN-negative patient groups.
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Tumor budding is defined by the presence of clusters of
undifferentiated malignant cells in the tumor stroma located in
close proximity ahead of the invasive front of a tumor [49–51].
Tumor budding has been reported to be an additional prognostic
factor for colorectal carcinoma (CRC) according to the Union for
International Cancer Control [52] and a potential prognostic factor in
early CRC according to the European Society for Medical Oncology
consensus guidelines [53]. Although evidence connecting tumor
budding and EMT is scarce [54], some reports have indicated that
EMT is significantly associated with tumor budding [55,56]. In our
study, EMT was observed in budding cells, and tumor budding was
promoted by the interaction between MSCs and the tumor stroma.
Moreover, EMT accompanied by FN expression correlated with
tumor budding and tumor progression.
In conclusion, MSCs induce EMT in colon cancer cells via direct
cell-to-cell contact and are associated with colon cancer metastasis.
Understanding the molecular mechanisms of this interaction between
tumor cells and MSCs may lead to the establishment of new therapies
targeting the tumor stroma.
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